Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine
Showing 1 - 25 of >10,000
HIV Trial in Bronx (Tenofovir gel, Tenofovir gel )
Completed
- HIV Infections
- Tenofovir gel
- Tenofovir gel placebo
-
Bronx, New YorkAlbert Einstein College of Medicine - East Campus GCRC (Herold)
Oct 28, 2021
HIV Trial in South Africa, Uganda, United States (Tenofovir disoproxil fumarate, Tenofovir gel)
Completed
- HIV Infections
- Tenofovir disoproxil fumarate
- Tenofovir gel
-
Birmingham, Alabama
- +6 more
Oct 15, 2021
SARS-CoV-2 Infection, Acute Kidney Injury Trial in New York, San Antonio, Seattle (Placebo, Nicotinamide riboside)
Active, not recruiting
- SARS-CoV-2 Infection
- Acute Kidney Injury
- Placebo
- Nicotinamide riboside
-
New York, New York
- +3 more
Oct 25, 2022
Ketoses, Metabolic, Ketogenic Dieting, Alcohol Intoxication Trial in Philadelphia (dietary supplement, other, drug)
Not yet recruiting
- Ketoses, Metabolic
- +4 more
- Ketone Supplement
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Center for Studies of Addiction
Sep 29, 2023
NAD Trial in Berlin (Niagen, Placebo)
Not yet recruiting
- NAD
- Niagen
- Placebo
-
Berlin, GermanySurgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Aug 22, 2023
Friedreich Ataxia Trial in Philadelphia (MIB-626)
Active, not recruiting
- Friedreich Ataxia
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 26, 2022
Novel Approaches for Quantitative Assessment of Adherence
Active, not recruiting
- Healthy
- Adenine 5+ (five stable-labeled nitrogens)
-
Aurora, ColoradoUniversity of Colorado- Anschutz Medical Campus
May 2, 2022
Genetic Variants in Nicotinamide Adenine Dinucleotide Synthesis
Active, not recruiting
- Vacterl Association
- Congenital Malformation
-
Rochester, MinnesotaMayo Clinic
Jan 10, 2023
Prospective Single-Timepoint Huntington's Disease Biospecimen
Recruiting
- Huntington Disease
- +3 more
- Biospecimen Collection
-
Woburn, MassachusettsSanguine Biosciences, Inc.
Mar 21, 2023
Prospective Research Rare Kidney Stones (ProRKS)
Recruiting
- Hyperoxaluria
- +4 more
-
Birmingham, Alabama
- +10 more
Nov 10, 2022
Hypertension Trial in Poznan (beetroot juice, nitrate)
Enrolling by invitation
- Hypertension
- beetroot juice
- nitrate
-
Poznan, PolandAkademia Wychowania Fizycznego
Jul 23, 2022
Danon Disease Trial in La Jolla, Philadelphia (RP-A501)
Recruiting
- Danon Disease
- RP-A501
-
La Jolla, California
- +1 more
Oct 17, 2023
Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- GARDASIL® 9
-
Kunming, Yunnan, ChinaYunnan Center for Disease Prevention and Control
Dec 23, 2022
Medication Use Among American Indians Adults
Withdrawn
- Type 2 Diabetes
- Medication Adherence
- (no location specified)
Sep 29, 2023
Red Blood Cell Disorder Trial in Hangzhou (blood preservation solution III)
Not yet recruiting
- Red Blood Cell Disorder
- blood preservation solution III
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University anesthesio
Mar 3, 2022
Pneumonia Trial in France, Tunisia (PRISTINAMYCIN XRP7263, Amoxicillin, Amoxicillin Placebo)
Recruiting
- Pneumonia
- PRISTINAMYCIN XRP7263
- +3 more
-
Avoine, France
- +18 more
Jan 9, 2023
Sudden Sensorineural Hearing Loss Trial in Guangzhou (Coenzyme I for Injection + conventional treatment, Conventional treatment)
Recruiting
- Sudden Sensorineural Hearing Loss
- Coenzyme I for Injection + conventional treatment
- Conventional treatment
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
May 8, 2023
Preterm Birth, Developmental Delay, Growth Delay Trial in Alkmaar (CBCL, SDQ, CCC-2-NL)
Enrolling by invitation
- Preterm Birth
- +2 more
- CBCL
- +8 more
-
Alkmaar, NetherlandsNoordwest Ziekenhuisgroep
Aug 6, 2023
Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)
Recruiting
- Advanced Breast Cancer
- TQB3909 tablets
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Mar 16, 2023
Resilience, Psychological, Advance Care Planning Trial (Web-based resilience-building intervention)
Not yet recruiting
- Resilience, Psychological
- Advance Care Planning
- Web-based resilience-building intervention
- (no location specified)
Sep 25, 2023
Papillomavirus Infections Trial in Quzhou, Taizhou (9vHPV vaccine)
Active, not recruiting
- Papillomavirus Infections
- 9vHPV vaccine
-
Quzhou, Zhejiang, China
- +1 more
Sep 1, 2022
HPV Infection Trial in Boston (Gardasil 9 2 dose regimen, Gardasil 9 3 dose regimen, Gardasil 9 rescue dose)
Recruiting
- HPV Infection
- Gardasil 9 2 dose regimen
- +2 more
-
Boston, MassachusettsBoston Medical Center
Dec 16, 2022
HER2-positive Breast Cancer Trial in Nanjing (HS022, Trastuzumab, Vinorelbine Bitartrate)
Completed
- HER2-positive Breast Cancer
- HS022
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Province People's Hospital (First Affiliated Hospital of
Oct 25, 2023
Cognitive Impairment, Sleep Quality Trial in Buffalo (Nicotinamide riboside, Placebo)
Not yet recruiting
- Cognitive Impairment
- Sleep Quality
- Nicotinamide riboside
- Placebo
-
Buffalo, New York
- +1 more
Aug 10, 2022
HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir
Not yet recruiting
- HIV
- Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
- Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
- (no location specified)
Nov 13, 2023